— Know what they know.
Not Investment Advice
Also trades as: 0LDR.L (LSE) · $vol 0M · 4LL.F (FSX) · $vol 0M

TDOC NYSE

Teladoc Health, Inc.
1W: -0.8% 1M: +10.8% 3M: +38.4% YTD: -7.0% 1Y: -10.6% 3Y: -72.6% 5Y: -95.3%
$6.57
+0.00 (+0.00%)
 
Weekly Expected Move ±7.3%
$5 $6 $6 $7 $7
NYSE · Healthcare · Medical - Healthcare Information Services · Alpha Radar Neutral · Power 56 · $1.2B mcap · 176M float · 3.04% daily turnover · Short 54% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
41.2 / 100
NoneWeakNarrowWide
Primary source: Cost Advantage  ·  ROIC: -9.2%  ·  5Y Avg: -67.4%
Cost Advantage ★
51
Intangibles
47
Switching Cost
33
Network Effect
38
Scale
35
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. TDOC shows a Weak competitive edge (41.2/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Cost Advantage. Negative ROIC of -9.2% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$0
Low
$7
Avg Target
$8
High
Based on 9 analyst ratings (12 mo)
Analyst Recommendations
Strong Buy: 0Buy: 14Hold: 28Sell: 0Strong Sell: 0
Rating Summary
ConsensusHold
Avg Target$7.25
Analysts4
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-04-08 Evercore ISI $9 $6 -3 +13.9% $5.27
2026-03-10 Deutsche Bank George Hill $18 $11 -7 +97.3% $5.58
2026-02-26 Stifel Nicolaus David Grossman $8 $6 -2 +18.3% $5.07
2026-02-26 Wells Fargo Stephen Baxter $40 $6 -34 +29.0% $4.65
2026-01-16 Goldman Sachs $9 $8 -1 +22.5% $6.53
2026-01-09 Goldman Sachs David Roman $55 $9 -46 +18.3% $7.61
2025-12-08 Barclays $20 $8 -12 +12.4% $7.56
2025-10-30 Stifel Nicolaus David Grossman $36 $8 -28 -9.3% $8.82
2025-07-30 Raymond James Initiated $10 +35.1% $7.40
2024-12-04 Piper Sandler Jessica Tassan $10 $13 +3 +18.1% $11.01
2024-10-31 Citigroup Daniel Grosslight $33 $11 -22 +24.2% $8.86
2024-10-30 Evercore ISI Elizabeth Anderson $28 $9 -19 +1.6% $8.86
2024-08-06 Piper Sandler Jessica Tassan $40 $10 -30 +31.6% $7.60
2024-06-11 Barclays Steve Valiquette $42 $20 -22 +90.7% $10.48
2024-05-31 Jefferies Glen Santangelo $14 $10 -4 -11.4% $11.29
2024-05-20 Jefferies Glen Santangelo $82 $14 -68 +13.0% $12.39
2024-04-05 Deutsche Bank George Hill $31 $18 -13 +22.9% $14.64
2023-04-12 Stephens Jeff Garro $135 $25 -110 -3.3% $25.86
2022-12-13 Citigroup $43 $33 -10 +19.4% $27.63
2022-09-28 RBC Capital $65 $35 -30 +27.2% $27.52
2022-09-27 Deutsche Bank $44 $31 -13 +17.6% $26.37
2022-07-30 Barclays Steve Valiquette $40 $42 +2 +14.0% $36.85
2022-07-28 Barclays $45 $40 -5 +18.3% $33.82
2022-07-28 Oppenheimer $130 $55 -75 +27.2% $43.24
2022-07-28 Piper Sandler Jessica Tassan $42 $40 -2 -7.5% $43.24
2022-07-27 Evercore ISI Elizabeth Anderson CFA $30 $28 -2 -35.2% $43.24
2022-06-29 Stifel Nicolaus $74 $36 -38 +4.8% $34.34
2022-05-26 Goldman Sachs Initiated $55 +63.8% $33.58
2022-05-17 Piper Sandler Jessica Tassan Initiated $42 +27.9% $32.85
2022-04-28 Craig-Hallum $67 $30 -37 -11.2% $33.77
2022-04-28 Canaccord Genuity $112 $50 -62 +48.0% $33.78
2022-04-28 Deutsche Bank Initiated $44 +30.0% $33.84
2022-04-28 RBC Capital $65 $65 0 +121.2% $29.38
2022-04-28 Citigroup Initiated $43 +46.8% $29.30
2022-04-28 Credit Suisse $35 $35 0 -37.5% $55.99
2022-04-28 Needham $100 $48 -52 -14.3% $55.99
2022-04-28 Leerink Partners $35 $35 0 -37.5% $55.99
2022-04-27 Barclays Steven Valiquette $77 $45 -32 +34.3% $33.51
2022-04-27 Credit Suisse Jonathan Yong Initiated $35 +4.4% $33.51
2022-04-27 Wells Fargo Stan Berenshteyn $121 $40 -81 +19.4% $33.51
2022-04-27 RBC Capital Sean Dodge Initiated $65 +94.0% $33.51
2022-04-27 Evercore ISI Elizabeth Anderson CFA $70 $30 -40 -10.5% $33.51
2022-04-27 Leerink Partners Stephanie Davis Initiated $35 +4.4% $33.51
2022-04-26 Robert W. Baird Vikram Kesavabhotla $72 $38 -34 -32.1% $55.99
2022-03-18 Cowen & Co. Charles Rhyee Initiated $94 +36.3% $68.96
2022-02-27 Jefferies Glen Santangelo Initiated $82 +8.0% $75.91
2022-02-27 Berenberg Bank Dev Weerasuriya Initiated $141 +85.7% $75.91
2022-02-22 Craig-Hallum Matt Hewitt Initiated $67 +9.0% $61.46
2022-02-22 Oppenheimer Michael Wiederhorn Initiated $130 +111.5% $61.46
2022-02-22 Canaccord Genuity Richard Close Initiated $112 +82.2% $61.46

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C+
May 22, 2026
DCF
5
ROE
1
ROA
1
D/E
1
P/E
1
P/B
4
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. TDOC receives an overall rating of C+. Strongest factors: DCF (5/5), P/B (4/5). Areas of concern: ROE (1/5), ROA (1/5), D/E (1/5), P/E (1/5).
Rating Change History
DateFromTo
2026-05-14 B- C+
2026-04-29 C+ B-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

36 Grade D
Profitability
16
Balance Sheet
43
Earnings Quality
47
Growth
66
Value
49
Momentum
64
Safety
0
Cash Flow
52
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. TDOC scores highest in Growth (66/100) and lowest in Safety (0/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-6.18
Distress Zone
Piotroski F-Score
5/9
Beneish M-Score
-3.04
Unlikely Manipulator
Ohlson O-Score
-7.43
Bankruptcy prob: 0.1%
Low Risk
Credit Rating
B
Score: 26.2/100
Trend: Improving
Earnings Quality
OCF/NI: -1.68x
Accruals: -13.9%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. TDOC scores -6.18, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. TDOC scores 5/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. TDOC's score of -3.04 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. TDOC's implied 0.1% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. TDOC receives an estimated rating of B (score: 26.2/100), with a improving trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-6.88x
PEG
-0.06x
P/S
0.47x
P/B
0.88x
P/FCF
3.89x
P/OCF
3.39x
EV/EBITDA
19.28x
EV/Revenue
0.49x
EV/EBIT
-7.30x
EV/FCF
4.92x
Earnings Yield
-17.53%
FCF Yield
25.72%
Shareholder Yield
0.00%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. TDOC currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.925
NI / EBT
×
Interest Burden
1.094
EBT / EBIT
×
EBIT Margin
-0.067
EBIT / Rev
×
Asset Turnover
0.760
Rev / Assets
×
Equity Multiplier
2.300
Assets / Equity
=
ROE
-11.9%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. TDOC's ROE of -11.9% is driven by Asset Turnover (0.760), indicating efficient use of assets to generate revenue. A tax burden ratio of 0.92 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$6.58
Median 1Y
$4.04
5th Pctile
$1.37
95th Pctile
$11.87
Ann. Volatility
63.8%
Analyst Target
$7.25
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Charles Divita, III
Chief executive officer
$800,000 $9,699,996 $11,202,996
Mala Murthy* financial
ief financial officer
$489,375 $3,299,998 $3,803,373
Carlos Nueno President,
international
$589,552 $2,000,000 $3,249,126
Kelly Bliss President,
U.S. group health
$516,667 $2,099,997 $2,962,164
Adam C. Vandervoort
Chief legal officer and secretary
$495,000 $2,099,997 $2,855,997

CEO Pay Ratio

58:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $11,202,996
Avg Employee Cost (SGA/emp): $193,797
Employees: 5,600

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
5,600
+1.8% YoY
Revenue / Employee
$451,782
Rev: $2,529,977,000
Profit / Employee
$-35,772
NI: $-200,322,000
SGA / Employee
$193,797
Avg labor cost proxy
R&D / Employee
$49,629
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE -9.0% -9.6% -2.7% -43.2% -61.8% -61.8% -1.5% -76.9% -43.8% -43.6% -9.5% -10.1% -43.4% -42.4% -52.5% -53.0% -10.9% -11.7% -13.9% -11.9% -11.90%
ROA -7.9% -8.4% -2.4% -38.9% -55.6% -55.6% -1.2% -62.9% -35.8% -35.7% -4.8% -5.1% -22.1% -21.6% -25.3% -25.6% -5.2% -5.7% -6.1% -5.2% -5.17%
ROIC -3.1% -3.3% -1.3% -32.9% -47.4% -47.5% -3.6% -1.9% -1.1% -1.1% -7.0% -7.3% -29.1% -28.5% -45.4% -46.9% -11.9% -12.2% -12.6% -9.2% -9.18%
ROCE -3.1% -3.5% -1.4% -1.3% -1.3% -1.3% -5.3% -5.2% -5.1% -5.0% -5.3% -5.7% -5.4% -4.9% -8.1% -7.2% -7.1% -7.3% -6.5% -6.3% -6.27%
Gross Margin 68.1% 67.6% 68.4% 66.9% 69.2% 69.6% 70.4% 69.8% 70.8% 71.8% 70.7% 69.9% 70.7% 71.9% 70.5% 68.7% 69.8% 70.1% 69.3% 52.8% 52.79%
Operating Margin -15.7% -11.6% -7.5% -11.8% -5.2% -11.7% -6.0% -12.3% -11.0% -9.8% -5.3% -13.5% -1.3% -6.9% -7.5% -19.2% -8.6% -8.3% -5.6% -7.9% -7.94%
Net Margin -26.6% -16.2% -2.0% -11.8% -5.2% -12.0% -6.0% -11.0% -10.0% -8.6% -4.4% -12.7% -1.3% -5.2% -7.6% -14.8% -5.2% -7.9% -3.9% -10.4% -10.40%
EBITDA Margin -3.1% -0.7% 0.2% -2.1% -1.8% -2.2% 3.3% -1.6% -0.5% 2.0% 6.6% -1.6% 2.6% 2.1% 1.8% -1.4% 0.4% -5.6% 8.0% 7.4% 7.41%
FCF Margin -3.9% -0.6% 9.1% 7.9% 9.4% 8.3% 7.2% 8.9% 9.0% 9.2% 11.8% 11.6% 11.2% 11.7% 8.9% 8.1% 8.3% 7.9% 9.0% 10.0% 9.99%
OCF Margin -3.0% -0.2% 9.5% 8.4% 9.9% 8.9% 7.9% 9.5% 9.6% 11.1% 13.4% 13.2% 12.8% 13.0% 11.4% 11.8% 11.9% 11.6% 11.6% 11.5% 11.45%
ROE 3Y Avg snapshot only -30.09%
ROE 5Y Avg snapshot only -87.79%
ROA 3Y Avg snapshot only -13.20%
ROIC 3Y Avg snapshot only -16.71%
ROIC Economic snapshot only -6.35%
Cash ROA snapshot only 9.29%
Cash ROIC snapshot only 17.51%
CROIC snapshot only 15.27%
NOPAT Margin snapshot only -6.00%
Pretax Margin snapshot only -7.36%
R&D / Revenue snapshot only 12.73%
SGA / Revenue snapshot only 42.18%
SBC / Revenue snapshot only 2.78%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -34.00 -24.91 -34.25 -1.68 -0.54 -0.42 -0.28 -0.60 -1.03 -0.77 -16.24 -10.87 -1.66 -1.60 -1.57 -1.37 -7.39 -6.07 -6.16 -5.70 -6.876
P/S Ratio 15.93 10.86 7.22 5.40 2.40 1.76 1.59 1.71 1.64 1.19 1.38 0.97 0.64 0.61 0.61 0.54 0.60 0.54 0.49 0.39 0.472
P/B Ratio 1.63 1.27 0.92 0.72 0.33 0.26 1.66 1.83 1.80 1.33 1.54 1.09 0.72 0.68 1.05 0.93 1.03 0.91 0.89 0.70 0.881
P/FCF -409.29 -1851.97 79.19 68.14 25.53 21.16 22.19 19.24 18.18 12.93 11.67 8.34 5.72 5.21 6.83 6.72 7.30 6.83 5.42 3.89 3.888
P/OCF 75.71 64.23 24.30 19.81 20.26 18.02 17.11 10.75 10.22 7.32 5.00 4.66 5.35 4.61 5.05 4.64 4.19 3.39 3.390
EV/EBITDA -68.68 -50.89 -324.68 -406.74 -233.10 -130.44 -308.96 -388.50 -905.53 177.46 92.80 69.11 33.67 32.13 58.53 50.96 96.31 -55.38 154.84 19.28 19.284
EV/Revenue 16.35 11.23 7.41 5.58 2.57 1.93 1.87 1.98 1.91 1.45 1.56 1.15 0.82 0.79 0.72 0.66 0.72 0.65 0.59 0.49 0.491
EV/EBIT -49.23 -34.67 -63.06 -53.05 -25.91 -19.34 -19.81 -21.67 -21.84 -17.55 -19.23 -13.37 -9.94 -10.39 -8.89 -8.96 -9.91 -8.71 -8.51 -7.30 -7.304
EV/FCF -420.17 -1915.19 81.26 70.40 27.36 23.14 26.06 22.29 21.11 15.75 13.20 9.88 7.33 6.76 8.08 8.10 8.67 8.28 6.56 4.92 4.920
Earnings Yield -2.9% -4.0% -2.9% -59.6% -1.8% -2.4% -3.6% -1.7% -96.7% -1.3% -6.2% -9.2% -60.4% -62.4% -63.8% -73.0% -13.5% -16.5% -16.2% -17.5% -17.53%
FCF Yield -0.2% -0.1% 1.3% 1.5% 3.9% 4.7% 4.5% 5.2% 5.5% 7.7% 8.6% 12.0% 17.5% 19.2% 14.6% 14.9% 13.7% 14.6% 18.4% 25.7% 25.72%
EV/OCF snapshot only 4.290
EV/Gross Profit snapshot only 0.749
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 3.19 3.19 3.70 3.70 3.70 3.70 3.22 3.22 3.22 3.22 3.54 3.54 3.54 3.54 1.77 1.77 1.77 1.77 2.69 2.69 2.686
Quick Ratio 3.02 3.02 3.48 3.48 3.48 3.48 3.07 3.07 3.07 3.07 3.47 3.47 3.47 3.47 1.73 1.73 1.73 1.73 2.59 2.59 2.592
Debt/Equity 0.09 0.09 0.08 0.08 0.08 0.08 0.69 0.69 0.69 0.69 0.68 0.68 0.68 0.68 1.06 1.06 1.06 1.06 0.75 0.75 0.751
Net Debt/Equity 0.04 0.04 0.02 0.02 0.02 0.02 0.29 0.29 0.29 0.29 0.20 0.20 0.20 0.20 0.19 0.19 0.19 0.19 0.19 0.19 0.187
Debt/Assets 0.08 0.08 0.07 0.07 0.07 0.07 0.34 0.34 0.34 0.34 0.36 0.36 0.36 0.36 0.45 0.45 0.45 0.45 0.34 0.34 0.335
Debt/EBITDA -3.81 -3.59 -27.58 -43.52 -51.96 -37.24 -108.86 -126.12 -297.79 75.33 36.51 36.67 25.13 25.04 49.95 48.28 83.92 -53.37 107.90 16.24 16.238
Net Debt/EBITDA -1.78 -1.68 -8.28 -13.06 -15.59 -11.17 -45.87 -53.15 -125.49 31.74 10.74 10.79 7.40 7.37 9.02 8.72 15.16 -9.64 26.88 4.04 4.044
Interest Coverage -6.71 -7.33 -2.97 -3.54 -4.54 -6.43 -13.23 -13.29 -12.81 -12.72 -9.45 -9.90 -9.55 -8.74 -8.77 -7.80 -8.07 -8.74 -8.89 -8.76 -8.755
Equity Multiplier 1.12 1.12 1.11 1.11 1.11 1.11 2.04 2.04 2.04 2.04 1.89 1.89 1.89 1.89 2.36 2.36 2.36 2.36 2.24 2.24 2.238
Cash Ratio snapshot only 1.930
Debt Service Coverage snapshot only 3.316
Cash to Debt snapshot only 0.751
FCF to Debt snapshot only 0.241
Defensive Interval snapshot only 194.8 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.17 0.19 0.11 0.12 0.13 0.13 0.21 0.22 0.23 0.23 0.57 0.58 0.57 0.57 0.65 0.65 0.64 0.64 0.76 0.76 0.760
Inventory Turnover 18.90 21.18 10.04 10.67 11.01 11.27 11.50 11.54 11.67 11.67 17.70 17.81 17.75 17.61 22.21 22.28 22.35 22.57 20.21 22.65 22.650
Receivables Turnover 14.40 16.46 12.02 12.68 13.21 13.74 12.68 13.02 13.34 13.59 12.16 12.24 12.19 12.10 11.91 11.83 11.78 11.72 12.43 12.36 12.357
Payables Turnover 19.38 21.71 13.94 14.82 15.30 15.65 15.67 15.74 15.91 15.91 16.64 16.74 16.69 16.55 19.57 19.63 19.70 19.89 19.03 21.32 21.322
DSO 25 22 30 29 28 27 29 28 27 27 30 30 30 30 31 31 31 31 29 30 29.5 days
DIO 19 17 36 34 33 32 32 32 31 31 21 20 21 21 16 16 16 16 18 16 16.1 days
DPO 19 17 26 25 24 23 23 23 23 23 22 22 22 22 19 19 19 18 19 17 17.1 days
Cash Conversion Cycle 26 23 41 38 37 36 37 36 36 35 29 29 29 29 28 29 29 29 28 29 28.5 days
Fixed Asset Turnover snapshot only 47.361
Operating Cycle snapshot only 45.7 days
Cash Velocity snapshot only 3.219
Capital Intensity snapshot only 1.233
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 1.3% 1.1% 85.8% 56.9% 37.1% 24.8% 18.4% 15.2% 13.3% 11.0% 8.1% 6.0% 3.1% 0.4% -1.3% -2.5% -2.6% -2.4% -1.5% -1.5% -1.50%
Net Income -7.1% -6.4% 11.6% -9.5% -11.9% -11.1% -30.9% -2.2% 59.3% 59.4% 98.4% 96.7% 75.0% 75.5% -3.5% -3.3% 79.4% 77.2% 80.0% 83.1% 83.09%
EPS -3.0% -2.9% 29.1% -9.0% -11.5% -11.0% -30.4% -0.7% 60.0% 60.3% 98.4% 96.8% 75.9% 76.4% -3.4% -3.2% 80.0% 77.8% 80.4% 83.6% 83.56%
FCF -2.3% -1.2% 3.6% 3.0% 4.3% 18.7% -6.8% 29.0% 8.9% 22.5% 77.5% 38.5% 27.4% 27.3% -25.1% -32.0% -28.0% -34.3% -1.0% 21.7% 21.66%
EBITDA -20.7% -51.5% 86.6% 92.0% 93.6% 91.6% 68.6% 57.2% 78.4% 1.6% 4.0% 4.5% 12.9% 2.0% -27.3% -24.4% -70.2% -1.5% -69.6% 95.2% 95.18%
Op. Income -9.1% -9.8% 47.5% -11.0% -14.4% -13.5% -50.4% -3.1% 59.1% 59.2% 98.2% 96.3% 74.5% 75.0% -3.1% -3.1% 74.0% 72.7% 74.2% 81.9% 81.88%
OCF Growth snapshot only -4.23%
Asset Growth snapshot only -11.82%
Equity Growth snapshot only -7.07%
Debt Growth snapshot only -34.36%
Shares Change snapshot only 2.85%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 70.3% 71.0% 69.4% 67.4% 65.5% 64.8% 63.2% 59.8% 52.3% 43.8% 33.5% 24.2% 17.0% 11.6% 8.1% 6.0% 4.4% 2.9% 1.7% 0.6% 0.59%
Revenue 5Y 76.2% 76.6% 75.2% 72.8% 70.0% 64.4% 59.5% 54.6% 50.3% 47.3% 44.2% 41.8% 39.6% 37.9% 35.9% 33.3% 28.8% 23.9% 18.3% 13.0% 12.97%
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y 37.3%
EBITDA 5Y
Gross Profit 3Y 66.8% 69.2% 68.5% 67.3% 66.0% 65.7% 65.2% 63.6% 57.4% 49.7% 37.9% 27.1% 19.0% 13.2% 9.6% 7.4% 5.5% 3.5% 1.9% -1.4% -1.45%
Gross Profit 5Y 73.2% 73.7% 72.2% 69.8% 66.7% 61.6% 57.5% 53.3% 49.7% 47.5% 44.8% 43.0% 41.0% 39.2% 37.6% 35.5% 31.5% 26.5% 20.1% 12.8% 12.83%
Op. Income 3Y
Op. Income 5Y
FCF 3Y 4.0% 2.7% 1.1% 1.2% 68.2% 57.5% 7.4% 6.7% -0.0% 0.8% 9.6% 4.6% 4.62%
FCF 5Y 1.8% 1.4% 64.7% 57.6% 34.3% 26.8%
OCF 3Y 4.4% 1.7% 1.4% 85.1% 95.3% 58.6% 53.1% 14.8% 18.6% 11.2% 12.2% 15.9% 7.1% 7.13%
OCF 5Y 2.1% 98.1% 88.4% 58.0% 57.1% 37.9% 29.7%
Assets 3Y 1.8% 1.8% 1.3% 1.3% 1.3% 1.3% 43.1% 43.1% 43.1% 43.1% -37.2% -37.2% -37.2% -37.2% -41.7% -41.7% -41.7% -41.7% -13.0% -13.0% -12.95%
Assets 5Y 1.4% 1.4% 1.3% 1.3% 1.3% 1.3% 41.6% 41.6% 41.6% 41.6% 23.5% 23.5% 23.5% 23.5% 17.0% 17.0% 17.0% 17.0% -29.5% -29.5% -29.46%
Equity 3Y 2.1% 2.1% 1.5% 1.5% 1.5% 1.5% 31.5% 31.5% 31.5% 31.5% -47.3% -47.3% -47.3% -47.3% -54.7% -54.7% -54.7% -54.7% -15.6% -15.6% -15.64%
Book Value 3Y 1.3% 1.3% 90.9% 91.3% 91.6% 91.9% 0.6% 0.8% 2.0% 4.8% -51.6% -49.0% -48.8% -48.6% -55.9% -55.9% -56.0% -55.9% -17.9% -18.3% -18.26%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.78 0.78 0.81 0.85 0.87 0.89 0.91 0.93 0.94 0.95 0.96 0.96 0.94 0.90 0.85 0.81 0.78 0.74 0.71 0.67 0.668
Earnings Stability 0.48 0.48 0.68 0.49 0.48 0.48 0.45 0.73 0.45 0.46 0.16 0.18 0.13 0.12 0.03 0.00 0.00 0.00 0.02 0.18 0.184
Margin Stability 0.94 0.94 0.95 0.95 0.94 0.94 0.95 0.95 0.95 0.95 0.96 0.97 0.98 0.98 0.97 0.96 0.96 0.95 0.96 0.96 0.963
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Earn. Growth Consistency 0.00 0.00 0.50 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 0.00 0.00 1.00 1.00 0.50 0.50 0.500
FCF Positive Streak 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.50 0.50 0.95 0.50 0.50 0.50 0.50 0.99 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.500
Earnings Smoothness
ROE Trend 0.05 0.05 0.04 -0.36 -0.54 -0.53 -5.89 -2.82 -1.41 -1.40 2.88 1.64 0.75 0.75 2.34 0.90 0.95 0.93 0.24 0.27 0.266
Gross Margin Trend 0.02 0.03 0.03 0.02 0.03 0.03 0.03 0.03 0.03 0.02 0.02 0.02 0.02 0.01 0.01 0.00 -0.00 -0.01 -0.01 -0.05 -0.050
FCF Margin Trend -0.07 -0.04 0.11 0.09 0.08 0.05 0.06 0.08 0.06 0.05 0.04 0.03 0.02 0.03 -0.01 -0.02 -0.02 -0.03 -0.01 0.00 0.001
Sustainable Growth Rate
Internal Growth Rate
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 0.06 0.01 -0.45 -0.03 -0.02 -0.02 -0.01 -0.03 -0.06 -0.07 -1.59 -1.48 -0.33 -0.34 -0.29 -0.30 -1.46 -1.31 -1.47 -1.68 -1.682
FCF/OCF 1.31 2.63 0.96 0.94 0.95 0.94 0.91 0.94 0.94 0.83 0.88 0.88 0.87 0.89 0.78 0.69 0.69 0.68 0.77 0.87 0.872
FCF/Net Income snapshot only -1.467
OCF/EBITDA snapshot only 4.495
CapEx/Revenue 0.9% 0.4% 0.4% 0.5% 0.5% 0.6% 0.7% 0.6% 0.6% 1.9% 1.7% 1.6% 1.6% 1.4% 2.5% 3.7% 3.7% 3.7% 2.6% 1.5% 1.47%
CapEx/Depreciation snapshot only 0.158
Accruals Ratio -0.07 -0.08 -0.04 -0.40 -0.57 -0.57 -1.23 -0.65 -0.38 -0.38 -0.13 -0.13 -0.29 -0.29 -0.33 -0.33 -0.13 -0.13 -0.15 -0.14 -0.139
Sloan Accruals snapshot only -0.083
Cash Flow Adequacy snapshot only 7.811
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio
FCF Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Total Payout Ratio
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -0.2% -0.3% -0.3% -0.3% -0.4% -0.4% -0.3% -0.2% -0.3% -0.3% -0.2% -0.2% -0.4% -0.5% -0.4% -0.3% -0.1% -0.1% -0.1% -0.2% -0.23%
Total Shareholder Return -0.2% -0.3% -0.3% -0.3% -0.4% -0.4% -0.3% -0.2% -0.3% -0.3% -0.2% -0.2% -0.4% -0.5% -0.4% -0.3% -0.1% -0.1% -0.1% -0.2% -0.23%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.00 1.01 1.11 0.99 1.00 0.99 1.00 1.00 1.00 1.00 1.00 1.01 1.01 1.01 1.01 0.99 0.89 0.89 0.85 0.92 0.925
Interest Burden (EBT/EBIT) 1.41 1.33 1.61 30.80 44.75 42.75 60.09 31.29 18.20 18.81 1.04 1.03 4.65 4.94 4.76 5.50 1.27 1.32 1.34 1.09 1.094
EBIT Margin -0.33 -0.32 -0.12 -0.11 -0.10 -0.10 -0.09 -0.09 -0.09 -0.08 -0.08 -0.09 -0.08 -0.08 -0.08 -0.07 -0.07 -0.07 -0.07 -0.07 -0.067
Asset Turnover 0.17 0.19 0.11 0.12 0.13 0.13 0.21 0.22 0.23 0.23 0.57 0.58 0.57 0.57 0.65 0.65 0.64 0.64 0.76 0.76 0.760
Equity Multiplier 1.15 1.15 1.11 1.11 1.11 1.11 1.22 1.22 1.22 1.22 1.96 1.96 1.96 1.96 2.07 2.07 2.07 2.07 2.30 2.30 2.300
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-4.89 $-5.09 $-2.68 $-43.00 $-61.17 $-60.97 $-84.23 $-43.30 $-24.47 $-24.23 $-1.33 $-1.39 $-5.91 $-5.72 $-5.80 $-5.81 $-1.18 $-1.27 $-1.14 $-0.96 $-0.96
Book Value/Share $101.78 $99.63 $100.32 $99.95 $99.43 $99.21 $14.23 $14.16 $14.06 $13.98 $14.01 $13.87 $13.66 $13.56 $8.63 $8.56 $8.48 $8.49 $7.86 $7.74 $7.46
Tangible Book/Share $-4.60 $-4.51 $-2.31 $-2.30 $-2.28 $-2.28 $-3.71 $-3.70 $-3.67 $-3.65 $-2.56 $-2.53 $-2.50 $-2.48 $-1.29 $-1.28 $-1.27 $-1.27 $-1.10 $-1.09 $-1.09
Revenue/Share $10.44 $11.68 $12.71 $13.36 $13.84 $14.37 $14.84 $15.17 $15.42 $15.62 $15.67 $15.62 $15.33 $15.10 $14.87 $14.66 $14.45 $14.39 $14.36 $14.04 $14.04
FCF/Share $-0.41 $-0.07 $1.16 $1.06 $1.30 $1.20 $1.07 $1.35 $1.39 $1.44 $1.85 $1.81 $1.71 $1.76 $1.33 $1.19 $1.19 $1.13 $1.29 $1.40 $1.40
OCF/Share $-0.31 $-0.03 $1.21 $1.12 $1.37 $1.28 $1.17 $1.44 $1.48 $1.73 $2.11 $2.06 $1.96 $1.97 $1.70 $1.73 $1.72 $1.67 $1.67 $1.61 $1.61
Cash/Share $5.04 $4.93 $5.60 $5.58 $5.55 $5.54 $5.66 $5.64 $5.59 $5.56 $6.77 $6.70 $6.60 $6.55 $7.51 $7.46 $7.38 $7.39 $4.43 $4.36 $4.19
EBITDA/Share $-2.49 $-2.58 $-0.29 $-0.18 $-0.15 $-0.21 $-0.09 $-0.08 $-0.03 $0.13 $0.26 $0.26 $0.37 $0.37 $0.18 $0.19 $0.11 $-0.17 $0.05 $0.36 $0.36
Debt/Share $9.46 $9.26 $8.00 $7.97 $7.93 $7.92 $9.79 $9.74 $9.67 $9.61 $9.59 $9.49 $9.35 $9.28 $9.17 $9.10 $9.01 $9.02 $5.90 $5.81 $5.81
Net Debt/Share $4.42 $4.33 $2.40 $2.39 $2.38 $2.38 $4.12 $4.10 $4.07 $4.05 $2.82 $2.79 $2.75 $2.73 $1.66 $1.64 $1.63 $1.63 $1.47 $1.45 $1.45
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score -6.182
Altman Z-Prime snapshot only -15.599
Piotroski F-Score 3 3 6 4 5 5 4 4 5 5 6 6 5 6 3 3 4 4 5 5 5
Beneish M-Score -0.85 -0.92 -2.35 -4.20 -5.04 -5.05 -17.07 -10.56 -7.52 -7.55 -3.16 -3.18 -3.98 -3.97 -4.41 -4.40 -3.34 -3.29 -3.19 -3.04 -3.045
Ohlson O-Score snapshot only -7.428
Net-Net WC snapshot only $-3.50
EVA snapshot only $-315426469.90
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only B
Credit Score 61.14 61.93 68.78 67.92 53.43 47.86 36.86 36.54 37.62 26.86 26.62 27.38 26.77 26.62 21.55 22.12 21.46 30.97 26.43 26.15 26.150
Credit Grade snapshot only 15
Credit Trend snapshot only 4.028
Implied Spread (bps) snapshot only 750.000
Industry Credit Rank snapshot only 18
Sector Credit Rank snapshot only 13

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms